The University of Southampton
University of Southampton Institutional Repository

The effect of a duodenal-jejunal bypass liner on lipid profile and blood concentrations of long chain polyunsaturated fatty acids

The effect of a duodenal-jejunal bypass liner on lipid profile and blood concentrations of long chain polyunsaturated fatty acids
The effect of a duodenal-jejunal bypass liner on lipid profile and blood concentrations of long chain polyunsaturated fatty acids

Background & aims: Duodenal-jejunal bypass liners (DJBLs) prevent absorption in the proximal small intestine, the site of fatty acid absorption. We sought to investigate the effects of a DJBL on blood concentrations of essential fatty acids (EFAs) and bioactive polyunsaturated fatty acids (PUFAs). Methods: Sub-study of a multicentre, randomised, controlled trial with two treatment groups. Patients aged 18–65 years with type-2 diabetes mellitus and body mass index 30–50 kg/m 2 were randomised to receive a DJBL for 12 months or best medical therapy, diet and exercise. Whole plasma PUFA concentrations were determined at baseline, 10 days, 6 and 11.5 months; data were available for n = 70 patients per group. Results: Weight loss was significantly greater in the DJBL group compared to controls after 11.5 months: total body weight loss 11.3 ± 5.3% versus 6.0 ± 5.7% (mean difference [95% CI] = 5.27% [3.75, 6.80], p < 0.001). Absolute concentrations of both EFAs, linoleic acid and α-linolenic acid, and their bioactive derivatives, arachidonic acid, eicosapentaenoic acid, docosapentaenoic acid and docosahexaenoic acid, were significantly lower in the DJBL group than in the control group at 6 and 11.5 months follow-up. Total serum cholesterol, LDL-cholesterol and HDL-cholesterol were also significantly lower in the DJBL group. Conclusion: One year of DJBL therapy is associated with superior weight loss and greater reductions in total serum cholesterol and LDL-cholesterol, but also depletion of EFAs and their longer chain derivatives. DJBL therapy may need to be offset by maintaining an adequate dietary intake of PUFAs or by supplementation. Trial registration: ClinicalTrials.gov Identifier NCT02459561.

Duodenal-jejunal bypass liner, Endobarrier, Endoscopic bariatric therapies, Lipids, Obesity, Polyunsaturated fatty acids
0261-5614
Glaysher, Michael
965e02e5-5f16-4173-a507-2423fce132ad
Ward, James
60f0f480-9a50-4151-93d4-77c6a3730c3c
Aldhwayan, Madhawi
e6c33077-8262-4660-993a-bf804905e9ae
Ruban, Aruchuna
491af67b-a027-4017-8aa5-fd2f0b91dd97
Prechtl,, Christina Gabriele
2ae9edaa-b948-44e7-a61e-ac2f095354ec
Fisk, Helena
2483d346-75dd-41b3-a481-10f8bb39cd9f
Chhina, Navpreet
cdb47d66-baa0-4783-a1b0-77ddfc52ea88
Al-Najim, Werd
c93a3d26-0f3a-4878-b2d7-44b1ef463b8d
Smith, Claire
0260d7df-710e-4ad5-ab85-fd186baa7b79
Klimowska-Nassar, Natalia
3f43d195-d42a-4e7c-8c88-8c30879eb25f
Johnson, Nicholas
59098de9-7372-4102-b7ec-3e188dd881af
Falaschetti, Emmanuela
2091d7b3-ee2c-4140-be61-275e895a4177
Goldstone, Anthony P.
3025a558-e46b-4ad9-a9c1-d7a73021c253
Miras, Alexander Dimitri
11d917d8-c0fc-4c22-8600-9af978668fb1
Byrne, James
e3d5b8fe-1b69-441c-a173-e084fe5372a6
Calder, Philip
1797e54f-378e-4dcb-80a4-3e30018f07a6
Teare, Julian P
1cabe3fd-2b30-4ba1-892a-05fc21c48903
Glaysher, Michael
965e02e5-5f16-4173-a507-2423fce132ad
Ward, James
60f0f480-9a50-4151-93d4-77c6a3730c3c
Aldhwayan, Madhawi
e6c33077-8262-4660-993a-bf804905e9ae
Ruban, Aruchuna
491af67b-a027-4017-8aa5-fd2f0b91dd97
Prechtl,, Christina Gabriele
2ae9edaa-b948-44e7-a61e-ac2f095354ec
Fisk, Helena
2483d346-75dd-41b3-a481-10f8bb39cd9f
Chhina, Navpreet
cdb47d66-baa0-4783-a1b0-77ddfc52ea88
Al-Najim, Werd
c93a3d26-0f3a-4878-b2d7-44b1ef463b8d
Smith, Claire
0260d7df-710e-4ad5-ab85-fd186baa7b79
Klimowska-Nassar, Natalia
3f43d195-d42a-4e7c-8c88-8c30879eb25f
Johnson, Nicholas
59098de9-7372-4102-b7ec-3e188dd881af
Falaschetti, Emmanuela
2091d7b3-ee2c-4140-be61-275e895a4177
Goldstone, Anthony P.
3025a558-e46b-4ad9-a9c1-d7a73021c253
Miras, Alexander Dimitri
11d917d8-c0fc-4c22-8600-9af978668fb1
Byrne, James
e3d5b8fe-1b69-441c-a173-e084fe5372a6
Calder, Philip
1797e54f-378e-4dcb-80a4-3e30018f07a6
Teare, Julian P
1cabe3fd-2b30-4ba1-892a-05fc21c48903

Glaysher, Michael, Ward, James, Aldhwayan, Madhawi, Ruban, Aruchuna, Prechtl,, Christina Gabriele, Fisk, Helena, Chhina, Navpreet, Al-Najim, Werd, Smith, Claire, Klimowska-Nassar, Natalia, Johnson, Nicholas, Falaschetti, Emmanuela, Goldstone, Anthony P., Miras, Alexander Dimitri, Byrne, James, Calder, Philip and Teare, Julian P (2021) The effect of a duodenal-jejunal bypass liner on lipid profile and blood concentrations of long chain polyunsaturated fatty acids. Clinical Nutrition. (doi:10.1016/j.clnu.2020.10.026).

Record type: Article

Abstract

Background & aims: Duodenal-jejunal bypass liners (DJBLs) prevent absorption in the proximal small intestine, the site of fatty acid absorption. We sought to investigate the effects of a DJBL on blood concentrations of essential fatty acids (EFAs) and bioactive polyunsaturated fatty acids (PUFAs). Methods: Sub-study of a multicentre, randomised, controlled trial with two treatment groups. Patients aged 18–65 years with type-2 diabetes mellitus and body mass index 30–50 kg/m 2 were randomised to receive a DJBL for 12 months or best medical therapy, diet and exercise. Whole plasma PUFA concentrations were determined at baseline, 10 days, 6 and 11.5 months; data were available for n = 70 patients per group. Results: Weight loss was significantly greater in the DJBL group compared to controls after 11.5 months: total body weight loss 11.3 ± 5.3% versus 6.0 ± 5.7% (mean difference [95% CI] = 5.27% [3.75, 6.80], p < 0.001). Absolute concentrations of both EFAs, linoleic acid and α-linolenic acid, and their bioactive derivatives, arachidonic acid, eicosapentaenoic acid, docosapentaenoic acid and docosahexaenoic acid, were significantly lower in the DJBL group than in the control group at 6 and 11.5 months follow-up. Total serum cholesterol, LDL-cholesterol and HDL-cholesterol were also significantly lower in the DJBL group. Conclusion: One year of DJBL therapy is associated with superior weight loss and greater reductions in total serum cholesterol and LDL-cholesterol, but also depletion of EFAs and their longer chain derivatives. DJBL therapy may need to be offset by maintaining an adequate dietary intake of PUFAs or by supplementation. Trial registration: ClinicalTrials.gov Identifier NCT02459561.

Text
Endobarrier PUFA Clin Nutr - revision 2 clean - Accepted Manuscript
Download (275kB)

More information

Accepted/In Press date: 16 October 2020
e-pub ahead of print date: 22 October 2020
Published date: 12 April 2021
Additional Information: Acknowledgements The trial was funded by the Efficacy and Mechanism Evaluation (EME) Programme, a Medical Research Council and National Insti- tute for Health Research (NIHR) partnership. This paper presents independent research funded by the EME Programme and sup- ported by the NIHR Clinical Research Facilities and Biomedical Research Centres at Imperial College Healthcare NHS Trust and University Hospital Southampton NHS Foundation Trust.
Keywords: Duodenal-jejunal bypass liner, Endobarrier, Endoscopic bariatric therapies, Lipids, Obesity, Polyunsaturated fatty acids

Identifiers

Local EPrints ID: 444655
URI: http://eprints.soton.ac.uk/id/eprint/444655
ISSN: 0261-5614
PURE UUID: b0530b24-7ed2-4596-8441-8649ed631fa8
ORCID for Helena Fisk: ORCID iD orcid.org/0000-0002-9534-3246
ORCID for Philip Calder: ORCID iD orcid.org/0000-0002-6038-710X

Catalogue record

Date deposited: 28 Oct 2020 18:03
Last modified: 17 Mar 2024 03:30

Export record

Altmetrics

Contributors

Author: Michael Glaysher
Author: James Ward
Author: Madhawi Aldhwayan
Author: Aruchuna Ruban
Author: Christina Gabriele Prechtl,
Author: Helena Fisk ORCID iD
Author: Navpreet Chhina
Author: Werd Al-Najim
Author: Claire Smith
Author: Natalia Klimowska-Nassar
Author: Nicholas Johnson
Author: Emmanuela Falaschetti
Author: Anthony P. Goldstone
Author: Alexander Dimitri Miras
Author: James Byrne
Author: Philip Calder ORCID iD
Author: Julian P Teare

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×